STOK

$33.08+1.10%

1M+4.1%3M+13.1%1Y+238.9%Market Cap:$1.96B

STOKE THERAPEUTICS INCEarning 05/12Healthcare | Biotechnology

Stoke Therapeutics, Inc. is a pioneering biopharmaceutical company based in Bedford, Massachusetts, focused on developing groundbreaking antisense oligonucleotide (ASO) therapies to address the root causes of severe genetic disorders. Leveraging its proprietary technology platform, the company is committed to advancing genetic medicine through innovative research and development initiatives. With a strong pipeline of ASO therapies and a clear vision for transforming patient care, Stoke Therapeutics presents a compelling investment opportunity for institutional investors interested in the evolving landscape of genetic therapeutics.

Recently

Rotate your device to landscape for a better chart view.

STOK Price Trend and Signals

Rotate your device to landscape for a better chart view.

STOK Short Volume (from FINRA off-exchange and ATS venues)

STOK Short Interest

STOK Option Volumes & Open Interests (aggregated)

STOK Put Call Ratios and IV (aggregated)

STOK Financials

2026-04-24Somewhat Bearishmacd_signal

Dead cross above zero detected.

2026-04-17Somewhat Bullishprice_signal

Monthly high detected.

2026-04-14Somewhat Bullishprice_signal

Monthly high detected.

2026-04-08Bullishmacd_signal

Golden cross below zero detected.

2026-03-13Somewhat Bearishmacd_signal

Dead cross above zero detected.

2026-03-10Somewhat Bullishprice_signal

Yearly high detected.

2026-03-09Somewhat Bullishprice_signal

Yearly high detected.

2026-03-02Somewhat Bullishprice_signal

Yearly high detected.

2026-02-27Somewhat Bullishprice_signal

Yearly high detected.

2026-02-23Somewhat Bullishprice_signal

Yearly high detected.

2026-02-19Somewhat Bullishprice_signal

Monthly high detected.

2026-01-22Somewhat Bullishbottom_signal_v1